TY - JOUR AU - Ferlay, J. AU - Parkin, D. M. AU - Steliarova-Foucher, E. PY - 2010 DA - 2010// TI - Estimates of cancer incidence and mortality in Europe in 2008 JO - Eur J Cancer VL - 46 ID - Ferlay2010 ER - TY - JOUR AU - Cannistra, S. A. PY - 2004 DA - 2004// TI - Cancer of the ovary JO - N Engl J Med VL - 351 ID - Cannistra2004 ER - TY - JOUR AU - du Bois, A. AU - Luck, H. J. AU - Meier, W. AU - Adams, H. P. AU - Mobus, V. AU - Costa, S. PY - 2003 DA - 2003// TI - A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer JO - J Natl Cancer Inst VL - 95 ID - du Bois2003 ER - TY - JOUR AU - du Bois, A. AU - Herrstedt, J. AU - Hardy-Bessard, A. C. AU - Muller, H. H. AU - Harter, P. AU - Kristensen, G. PY - 2010 DA - 2010// TI - Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer JO - J Clin Oncol VL - 28 ID - du Bois2010 ER - TY - JOUR AU - Pfisterer, J. AU - Weber, B. AU - Reuss, A. AU - Kimmig, R. AU - du Bois, A. AU - Wagner, U. PY - 2006 DA - 2006// TI - Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO JO - J Natl Cancer Inst VL - 98 ID - Pfisterer2006 ER - TY - JOUR AU - Ozols, R. F. AU - Bundy, B. N. AU - Greer, B. E. AU - Fowler, J. M. AU - Clarke-Pearson, D. AU - Burger, R. A. PY - 2003 DA - 2003// TI - Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study JO - J Clin Oncol VL - 21 ID - Ozols2003 ER - TY - JOUR AU - Aapro, M. S. AU - Cameron, D. A. AU - Pettengell, R. AU - Bohlius, J. AU - Crawford, J. AU - Ellis, M. PY - 2006 DA - 2006// TI - EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours JO - Eur J Cancer VL - 42 ID - Aapro2006 ER - TY - JOUR AU - Nakajima, M. AU - Fujiki, Y. AU - Kyo, S. AU - Kanaya, T. AU - Nakamura, M. AU - Maida, Y. PY - 2005 DA - 2005// TI - Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1 JO - J Clin Pharmacol VL - 45 ID - Nakajima2005 ER - TY - JOUR AU - Bosch, T. M. AU - Huitema, A. D. AU - Doodeman, V. D. AU - Jansen, R. AU - Witteveen, E. AU - Smit, W. M. PY - 2006 DA - 2006// TI - Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel JO - Clin Cancer Res VL - 12 ID - Bosch2006 ER - TY - JOUR AU - Henningsson, A. AU - Marsh, S. AU - Loos, W. J. AU - Karlsson, M. O. AU - Garsa, A. AU - Mross, K. PY - 2005 DA - 2005// TI - Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel JO - Clin Cancer Res VL - 11 ID - Henningsson2005 ER - TY - JOUR AU - Sissung, T. M. AU - Mross, K. AU - Steinberg, S. M. AU - Behringer, D. AU - Figg, W. D. AU - Sparreboom, A. PY - 2006 DA - 2006// TI - Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia JO - Eur J Cancer VL - 42 ID - Sissung2006 ER - TY - JOUR AU - Marsh, S. AU - Paul, J. AU - King, C. R. AU - Gifford, G. AU - McLeod, H. L. AU - Brown, R. PY - 2007 DA - 2007// TI - Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer JO - J Clin Oncol VL - 25 ID - Marsh2007 ER - TY - JOUR AU - Johnatty, S. E. AU - Beesley, J. AU - Paul, J. AU - Fereday, S. AU - Spurdle, A. B. AU - Webb, P. M. PY - 2008 DA - 2008// TI - ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy JO - Clin Cancer Res VL - 14 ID - Johnatty2008 ER - TY - JOUR AU - Green, H. AU - Soderkvist, P. AU - Rosenberg, P. AU - Mirghani, R. A. AU - Rymark, P. AU - Lundqvist, E. A. PY - 2009 DA - 2009// TI - Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer JO - Basic Clin Pharmacol Toxicol VL - 104 ID - Green2009 ER - TY - JOUR AU - Kim, H. S. AU - Kim, M. K. AU - Chung, H. H. AU - Kim, J. W. AU - Park, N. H. AU - Song, Y. S. PY - 2009 DA - 2009// TI - Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study JO - Gynecol Oncol VL - 113 ID - Kim2009 ER - TY - JOUR AU - Bergmann, T. K. AU - Brasch-Andersen, C. AU - Green, H. AU - Mirza, M. AU - Pedersen, R. S. AU - Nielsen, F. PY - 2011 DA - 2011// TI - Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer JO - Pharmacogenomics J VL - 11 ID - Bergmann2011 ER - TY - JOUR AU - Tian, C. AU - Ambrosone, C. B. AU - Darcy, K. M. AU - Krivak, T. C. AU - Armstrong, D. K. AU - Bookman, M. A. PY - 2012 DA - 2012// TI - Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study JO - Gynecol Oncol VL - 124 ID - Tian2012 ER - TY - JOUR AU - Bergmann, T. K. AU - Brasch-Andersen, C. AU - Green, H. AU - Mirza, M. R. AU - Skougaard, K. AU - Wihl, J. PY - 2012 DA - 2012// TI - Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer JO - Basic Clin Pharmacol Toxico VL - 110 ID - Bergmann2012 ER - TY - JOUR AU - Kiyotani, K. AU - Mushiroda, T. AU - Kubo, M. AU - Zembutsu, H. AU - Sugiyama, Y. AU - Nakamura, Y. PY - 2008 DA - 2008// TI - Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia JO - Cancer Sci VL - 99 ID - Kiyotani2008 ER - TY - JOUR AU - Smith, N. F. AU - Acharya, M. R. AU - Desai, N. AU - Figg, W. D. AU - Sparreboom, A. PY - 2005 DA - 2005// TI - Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel JO - Cancer Biol Ther VL - 4 ID - Smith2005 ER - TY - JOUR AU - Chew, S. C. AU - Sandanaraj, E. AU - Singh, O. AU - Chen, X. AU - Tan, E. H. AU - Lim, W. T. PY - 2012 DA - 2012// TI - Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients JO - Br J Clin Pharmacol VL - 73 ID - Chew2012 ER - TY - JOUR AU - Crouthamel, M. H. AU - Wu, D. AU - Yang, Z. AU - Ho, R. J. PY - 2006 DA - 2006// TI - A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells JO - J Pharm Sci VL - 95 ID - Crouthamel2006 ER - TY - JOUR AU - Vanhoefer, U. AU - Cao, S. AU - Minderman, H. AU - Toth, K. AU - Scheper, R. J. AU - Slovak, M. L. PY - 1996 DA - 1996// TI - PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein JO - Clin Cancer Res VL - 2 ID - Vanhoefer1996 ER - TY - JOUR AU - Huisman, M. T. AU - Chhatta, A. A. AU - van Tellingen, O. AU - Beijnen, J. H. AU - Schinkel, A. H. PY - 2005 DA - 2005// TI - MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid JO - Int J Cancer VL - 116 ID - Huisman2005 ER - TY - JOUR AU - Leskela, S. AU - Jara, C. AU - Leandro-Garcia, L. J. AU - Martinez, A. AU - Garcia-Donas, J. AU - Hernando, S. PY - 2011 DA - 2011// TI - Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity JO - Pharmacogenomics J VL - 11 ID - Leskela2011 ER - TY - JOUR AU - Baker, S. D. AU - Verweij, J. AU - Cusatis, G. A. AU - van Schaik, R. H. AU - Marsh, S. AU - Orwick, S. J. PY - 2009 DA - 2009// TI - Pharmacogenetic pathway analysis of docetaxel elimination JO - Clin Pharmacol Ther VL - 85 ID - Baker2009 ER - TY - JOUR AU - Pearce, C. L. AU - Near, A. M. AU - Van Den Berg, D. J. AU - Ramus, S. J. AU - Gentry-Maharaj, A. AU - Menon, U. PY - 2009 DA - 2009// TI - Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium JO - Br J Cancer VL - 100 ID - Pearce2009 ER - TY - JOUR AU - Gadducci, A. AU - Di Cristofano, C. AU - Zavaglia, M. AU - Giusti, L. AU - Menicagli, M. AU - Cosio, S. PY - 2006 DA - 2006// TI - P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome JO - Anticancer Res VL - 26 ID - Gadducci2006 ER - TY - JOUR AU - Schildkraut, J. M. AU - Goode, E. L. AU - Clyde, M. A. AU - Iversen, E. S. AU - Moorman, P. G. AU - Berchuck, A. PY - 2009 DA - 2009// TI - Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer JO - Cancer Res VL - 69 ID - Schildkraut2009 ER - TY - JOUR AU - Lecomte, T. AU - Landi, B. AU - Beaune, P. AU - Laurent-Puig, P. AU - Loriot, M. A. PY - 2006 DA - 2006// TI - Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy JO - Clin Cancer Res VL - 12 ID - Lecomte2006 ER - TY - JOUR AU - Mir, O. AU - Alexandre, J. AU - Tran, A. AU - Durand, J. P. AU - Pons, G. AU - Treluyer, J. M. PY - 2009 DA - 2009// TI - Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity JO - Ann Oncol VL - 20 ID - Mir2009 ER - TY - JOUR AU - Khrunin, A. V. AU - Moisseev, A. AU - Gorbunova, V. AU - Limborska, S. PY - 2010 DA - 2010// TI - Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients JO - Pharmacogenomics J VL - 10 ID - Khrunin2010 ER - TY - JOUR AU - Khrunin, A. AU - Ivanova, F. AU - Moisseev, A. AU - Khokhrin, D. AU - Sleptsova, Y. AU - Gorbunova, V. PY - 2012 DA - 2012// TI - Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins JO - Pharmacogenomics VL - 13 ID - Khrunin2012 ER - TY - JOUR AU - Kang, S. AU - Ju, W. AU - Kim, J. W. AU - Park, N. H. AU - Song, Y. S. AU - Kim, S. C. PY - 2006 DA - 2006// TI - Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer JO - Exp Mol Med VL - 38 ID - Kang2006 ER - TY - JOUR AU - Krivak, T. C. AU - Darcy, K. M. AU - Tian, C. AU - Bookman, M. AU - Gallion, H. AU - Ambrosone, C. B. PY - 2011 DA - 2011// TI - Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study JO - Gynecol Oncol VL - 122 ID - Krivak2011 ER - TY - JOUR AU - Johnson, D. C. AU - Corthals, S. L. AU - Walker, B. A. AU - Ross, F. M. AU - Gregory, W. M. AU - Dickens, N. J. PY - 2011 DA - 2011// TI - Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma JO - J Clin Oncol VL - 29 ID - Johnson2011 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 ID - Eisenhauer2009 ER - TY - JOUR AU - Reumers, J. AU - De Rijk, P. AU - Zhao, H. AU - Liekens, A. AU - Smeets, D. AU - Cleary, J. PY - 2012 DA - 2012// TI - Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing JO - Nat Biotechnol VL - 30 ID - Reumers2012 ER - TY - JOUR AU - Marsh, S. PY - 2009 DA - 2009// TI - Pharmacogenomics of taxane/platinum therapy in ovarian cancer JO - Int J Gynecol Cancer VL - 19 ID - Marsh2009 ER - TY - JOUR AU - Brooks-Wilson, A. AU - Marcil, M. AU - Clee, S. M. AU - Zhang, L. H. AU - Roomp, K. AU - van Dam, M. PY - 1999 DA - 1999// TI - Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency JO - Nat Genet VL - 22 ID - Brooks-Wilson1999 ER - TY - JOUR AU - White, K. L. AU - Vierkant, R. A. AU - Fogarty, Z. C. AU - Charbonneau, B. AU - Block, M. S. AU - Pharoah, P. D. PY - 2013 DA - 2013// TI - Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome JO - Cancer Epidemiol Biomarkers Prev VL - 22 ID - White2013 ER - TY - JOUR AU - Krishnamurthy, P. C. AU - Du, G. AU - Fukuda, Y. AU - Sun, D. AU - Sampath, J. AU - Mercer, K. E. PY - 2006 DA - 2006// TI - Identification of a mammalian mitochondrial porphyrin transporter JO - Nature VL - 443 ID - Krishnamurthy2006 ER - TY - JOUR AU - Santibanez, M. AU - Gallardo, D. AU - Morales, F. AU - Lopez, A. AU - Prada, D. AU - Mendoza, J. PY - 2013 DA - 2013// TI - The MAD1 1673 G. A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer JO - Pharmacogenet Genomics VL - 23 ID - Santibanez2013 ER - TY - JOUR AU - McWhinney-Glass, S. AU - Winham, S. J. AU - Hertz, D. L. AU - Yen Revollo, J. AU - Paul, J. AU - He, Y. PY - 2013 DA - 2013// TI - Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity JO - Clin Cancer Res VL - 19 ID - McWhinney-Glass2013 ER -